Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | ZDHHC20 | Q5W0Z9 | 2/20 | 0.38 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16285077 | 0.79 | MGAM (0.41) | ALDH1A1ZDHHC20ZDHHC2TSHRPSMB5 | |
| SCHEMBL12831950 | 0.78 | ALDH1A1 (0.39) | ALDH1A1ZDHHC20ZDHHC2TSHRPSMB5 | |
| SCHEMBL6402606 | 0.77 | LMNA (0.38) | ALDH1A1ZDHHC20ZDHHC2TSHRPSMB5 | |
| SCHEMBL4365703 | 0.76 | ZDHHC20 (0.40) | ALDH1A1ZDHHC20ZDHHC2TSHRLMNA | |
| SCHEMBL16285114 | 0.76 | ZDHHC20 (0.36) | ALDH1A1ZDHHC20ZDHHC2TSHRPSMB5 | |
| SCHEMBL16281562 | 0.76 | CA12 (0.44) | ALDH1A1ZDHHC20ZDHHC2TSHRPSMB5 | |
| SCHEMBL224019 | 0.76 | — | — | |
| SCHEMBL14880 | 0.74 | — | — | |
| Water SCHEMBL11778100 | 0.74 | ZDHHC20 (0.40) | ALDH1A1ZDHHC20ZDHHC2TSHRTDP1 | |
| SCHEMBL423989 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 217 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103565558-B | High-strength double-network hydrogel/bioceramic composite stent and preparation method thereof | UNIV XI AN JIAOTONG | 2015-07-01 | — | — | CN | claimed |
| CN-103071187-B | Ligament-bone composite scaffold with biomimetic connecting interface and forming method thereof | UNIV XI AN JIAOTONG | 2014-04-23 | — | — | CN | claimed |
| CN-103565558-A | High-strength double-network hydrogel/bioceramic composite stent and preparation method thereof | UNIV XI AN JIAOTONG | 2014-02-12 | — | — | CN | claimed |
| CN-102335460-B | Magnesium alloy/biological ceramic bone bracket based on photocuring and gel casting and forming method of bone bracket | UNIV XI AN JIAOTONG | 2014-01-29 | — | — | CN | claimed |
| EP-2629780-A2 | IMPLANTABLE POLYMER FOR BONE AND VASCULAR LESIONS | 206 ORTHO, Inc. (US) | 2013-08-28 | — | — | EP | claimed |
| US-20120101593-A1 | IMPLANTABLE POLYMER FOR BONE AND VASCULAR LESIONS | BIOS2 Medical, Inc. (US) | 2012-04-26 | — | — | US | claimed |
| WO-2012054742-A2 | IMPLANTABLE POLYMER FOR BONE AND VASCULAR LESIONS | BIOS2 Medical, Inc. (US) | 2012-04-26 | — | — | WO | claimed |
| EP-0932652-B2 | USE OF POLYMER DISPERSIONS AS BINDING AGENTS FOR SEALING COMPOUNDS AND COATING COMPOUNDS | BASF SE (DE) | 2008-04-23 | — | — | EP | claimed |
| US-6610278-B2 | Hardness not greater than 75 as measured by an Asker rubber-hardness tester type C1L; a porosity of at least 0.4; and an impact resistance of at least 5; excellent skin feel upon use and is not easily broken. | KAO CORPORATION (JP) | 2003-08-26 | — | — | US | claimed |
| EP-0932652-B1 | USE OF POLYMER DISPERSIONS AS BINDING AGENTS FOR SEALING COMPOUNDS AND COATING COMPOUNDS | BASF AG (DE) | 2002-12-18 | — | — | EP | claimed |
| US-20020028220-A1 | POWDER-BASED SOLID COSMETIC COMPOSITION AND PREPARATION PROCESS THEREOF | KAO CORPORATION (JP) | 2002-03-07 | — | — | US | claimed |
| EP-0932652-A1 | USE OF POLYMER DISPERSIONS AS BINDING AGENTS FOR SEALING COMPOUNDS AND COATING COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 1999-08-04 | — | — | EP | claimed |
| WO-1998016589-A1 | USE OF POLYMER DISPERSIONS AS BINDING AGENTS FOR SEALING COMPOUNDS AND COATING COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 1998-04-23 | — | — | WO | claimed |
| EP-0188110-B1 | Hydrogel-forming polymers | TR DEV LTD (GB) | 1995-09-06 | — | — | EP | claimed |
| US-4687689-A | CROSSLINKING | TOYO SEIKAN KAISHA, LTD. (JP) | 1987-08-18 | — | — | US | claimed |
| JP-63106743-A | — | — | None | — | — | JP | disclosed |
| EP-3838934-B1 | ADHESIVE COMPOSITION FOR PAPER BONDING | TESA SE (DE) | 2025-05-14 | — | — | EP | disclosed |
| US-4067927-A | TEXTILES | STAUFFER CHEMICAL COMPANY (US) | 1978-01-10 | — | — | US | disclosed |
| US-4052158-A | CATALYTIC FREE RADICAL POLYMERIZATION, CURING | STAUFFER CHEMICAL COMPANY (US) | 1977-10-04 | — | — | US | disclosed |
| US-4017257-A | Textiles fire-retardant treated with copolycondensed vinylphosphonates and process | STAUFFER CHEMICAL COMPANY (US) | 1977-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020028220-A1 | POWDER-BASED SOLID COSMETIC COMPOSITION AND PREPARATION PROCESS THEREOF | CUTA, C1R, C1S | ALDH1A1 3005/4885ZDHHC20 853/4885ZDHHC2 2077/4885 |
| US-20120101593-A1 | IMPLANTABLE POLYMER FOR BONE AND VASCULAR LESIONS | BMP2, SOST, CD47 | ALDH1A1 2935/4885ZDHHC20 4505/4885ZDHHC2 4493/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.